September 8, 2025

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 44% Upside Potential and Strong Buy Consensus

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, represents an intriguing opportunity for investors seeking exposure to the healthcare industry. With its headquarters in Dublin, Ireland,..

Teleflex Incorporated (TFX) Stock Analysis: Evaluating Growth Potential in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, has long been known for its innovative solutions in medical instruments and supplies. With a market capitalization of $5.78..

Masimo Corporation (MASI) Investor Outlook: A Closer Look at its 27% Upside Potential

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, has caught the attention of investors with its significant upside potential. As a leading developer of patient monitoring technologies,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Eyeing a 16.2% Upside with Strong Analyst Support

GE HealthCare Technologies Inc. (NYSE: GEHC), a prominent player in the healthcare sector, is making waves among investors with its robust market presence and promising growth potential. With a market..

Waters Corporation (WAT) Stock Analysis: Unpacking the 13.33% Potential Upside in the Diagnostics & Research Sector

Waters Corporation (NYSE: WAT) stands as a prominent player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $18.23 billion, this Massachusetts-based company has been..

Moderna, Inc. (MRNA) Stock Analysis: Potential Upside and Challenges Amidst a 76% Growth Opportunity

Moderna, Inc. (NASDAQ: MRNA) has been at the forefront of the biotechnology sector, renowned for its pioneering work in messenger RNA (mRNA) therapeutics. While the company’s innovative portfolio spans respiratory..

Glaukos Corporation (GKOS) Investor Outlook: A Look at the 30% Upside Potential

Glaukos Corporation (NYSE: GKOS) is making waves in the healthcare sector with its innovative medical devices focused on treating eye disorders. With a current market capitalization of $5.39 billion, this..

Solventum Corporation (SOLV) Stock Analysis: Exploring a Potential 19% Upside

Solventum Corporation (SOLV), a key player in the healthcare sector specializing in medical instruments and supplies, has emerged as an intriguing opportunity for investors seeking growth in a dynamic market...

Stevanato Group S.p.A. (STVN) Stock Analysis: A Promising 18.6% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN) is capturing the attention of investors with a compelling potential upside of 18.6%, driven by its robust presence in the healthcare sector. Based in Piombino..

Molina Healthcare Inc (MOH): Stock Analysis Reveals 12.63% Potential Upside Amid Healthcare Sector Growth

Molina Healthcare Inc (NYSE: MOH), a formidable player in the healthcare plans industry, stands out with its robust market capitalization of $9.47 billion. Headquartered in Long Beach, California, the company..

Align Technology, Inc. (ALGN) Stock Analysis: Is a 33.95% Upside Within Reach?

Align Technology, Inc. (NASDAQ: ALGN) has long been a pioneer in the healthcare sector, particularly in the medical instruments and supplies industry. Known for its innovative Invisalign clear aligners and..

CVS Health Corporation (CVS) Stock Analysis: Unveiling an 11.24% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, CVS Health Corporation (NYSE: CVS) presents an intriguing proposition. With its operations spanning Health Care Benefits, Health Services, and Pharmacy & Consumer..

Grifols, S.A. (GRFS) Stock Analysis: Discovering a 20% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare industry specializing in plasma-derived therapies, is capturing the attention of investors with its promising upside potential. Currently priced at $10.13,..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and 20.66% Upside Potential

Investors seeking stability in the dynamic healthcare sector may find Cardinal Health, Inc. (NYSE: CAH) an intriguing prospect. With a substantial market capitalization of $35.71 billion, Cardinal Health is a..

Viatris Inc. (VTRS) Stock Analysis: Exploring the 8.84% Potential Upside for Investors

Viatris Inc. (VTRS), a significant player in the healthcare sector, has been drawing attention from investors thanks to its strategic positioning in the drug manufacturing industry—specializing in both specialty and..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Diagnostics Landscape with a 5.82% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, specifically within the Diagnostics & Research industry. With its extensive reach across the United..

BeOne Medicines Ltd. (ONC): A Healthcare Titan with a 7.57% Potential Upside and Strong Buy Ratings

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology industry, is making waves with its robust pipeline of oncology treatments and strategic partnerships. Based in Basel, Switzerland, this healthcare..

Insulet Corporation (PODD) Stock Analysis: Riding High on Revenue Growth and Strong Buy Ratings

Insulet Corporation (NASDAQ: PODD), a leading player in the healthcare sector’s medical devices industry, has been making waves with its innovative insulin delivery systems. With a market capitalization of $24.53..

West Pharmaceutical Services (WST) Stock Analysis: 26% Potential Upside Awaits Investors

West Pharmaceutical Services, Inc. (NYSE: WST), a leader in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $18.03 billion, this..

Stryker Corporation (SYK) Stock Analysis: Exploring a Strong 10.42% Potential Upside

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, is capturing investor attention with its robust market cap of $149.98 billion and an enticing potential upside of 10.42%. As..

Search

Funds

September 8, 2025

Search

Funds

September 8, 2025

FTSE 100

Funds